Latvian Government Partners with Pharma in Signing Letter of Intent
The Latvian government and Pharma have signed a letter of intent on June 29, 2015, agreeing on measures and a mutual cooperation in projects that will help improve medicines access and health outcomes in Latvia.
The Latvian Ministry of Health, the Latvian Academy of Sciences, the European Association of Pharmaceutical Industries and Associations (EFPIA), and the Association of International Research-based Pharmaceutical Manufacturers (SIFFA) have signed a letter of intent on June 29, 2015, agreeing on measures and a mutual cooperation in projects that will help improve medicines access and health outcomes in Latvia.
The government is hoping to promote stable business conditions while improving access to innovative medicines and investments in research. The Ministry of Health and the pharmaceutical industry have agreed on the provision of transparency in the reimbursed medicines system, availability of medicines, result-oriented uptake of medicines, and the industry’s support to ensure the availability of medicines. A working group will be established to develop specific proposals for a step wise collaboration.
The letter of intent underscores the continued efforts of the research-based pharmaceutical industry to forge partnership with governments across Europe to support the sustainability of national health services and increase access to innovative medicines for the benefit of patients.
Source: EFPIA
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
